Aeon Astron

Home  company  Milestone
Milestone



2015
MonthTitle
12Aeon Astron Europe B.V. Obtained IRB approvals from the German Federal Institute for Drugs and Medical Devices (BfArM) and the University of Cologne to start clinical trial for ologen® Biocornea Type E.
12Aeon Astron Europe B.V. with it its lead program on ologen® Biocornea is part of a consortium of leading universities in Europe. The consortium ARREST BLINDNESS is recipient of EUR 5.99 million Horizon2020 grant.
12Obtained medical device approval and registration from the Taiwan Food and Drug Administration, Ministry of Health and Welfare for Aongen® Collagen Membrane.
5BOBC obtained certified High Tech Industry status from the Taiwan Industrial Development Bureau, Ministry of Economic Affairs.
2014
MonthTitle
5USA HCPCS public hearing
5ologen® Collagen Matrix obtained KGMP certificate.
4ologen® Collagen Matrix vs. MMC in Trabeculectomy- A Five-Year report at 2014 WOC, Tokyo
2013
MonthTitle
11ologen® Collagen Matrix for congenital glaucoma: comparative results at 2013 AAO, New Orleans.
11ologen® Collagen Matrix attained health approval in Iran.
11A US 12-month retrospective review using ologen Collagen Matrix with Ex-PRESS in trabeculectomy on J Glaucoma
10ologen® Collagen Matrix attained health approval in Peru.
7ologen® Collagen Matrix for congenital glaucoma: presentation at 2013 WGC, Vancouver.
6ologen® Collagen Matrix for congenital glaucoma: case report at SOE 2013 Congress, Copenhagen.
3ologen® Collagen Matrix attained health approval in Mexico.
1The number of ologen Collagen Matrix's SCI/SCIE publications reaches fifteen (15).
2012
MonthTitle
8ologen® Collagen Matrix attained health approval in Vietnam.
7ologen® Collagen Matrix attained health approval in Saudi Arabia.
5Founding of the Network of Excellence in Corneal Regeneration (NEXCR).
3Aeon Astron Europe B.V. received grant EURO 3 million for its BioCornea project from Innovatiefond MKB , Dept. of Economic Affairs of the Netherlands.
3ologen® Collagen Matrix attained health approval in Argentina.
2011
MonthTitle
12Aeon Astron Europe B.V. received grant EURO 500,000 from AgentschapNL, Dept. of Economic Affairs of the Netherlands.
9ologen® Collagen Matrix attained Canada Medical Device License.
9ologen® Collagen Matrix two-year randomized controlled study by Dr. Cillino et al.
8ologen® Collagen Matrix is reimbursed in Tunisia.
5ologen® Collagen Matrix attained health approval in Egypt.
1Aeon Astron Europe B.V. is the Glaucoma Industry member of WGA.
2010
MonthTitle
8ologen® Collagen Matrix attained health approval in Jordan.
7ologen® Collagen Matrix obtained CMDCAS certificate.
4ologen® Collagen Matrix is reimbursed by the Medicare System in Sweden.
1ologen® Collagen Matrix is reimbursed by the General Insurance Agency in Czech.
2009
MonthTitle
12Aeon Astron Europe B.V. received grant EURO 300,000 for its BioCornea project from AgentschapNL, Dept. of Economic Affairs of the Netherlands.
12ologen® Collagen Matrix attained Indian health registration certificate.
8ologen® and Aongen® received US FDA 510K clearance letter.
2008
MonthTitle
11The brand oculusgen has been changed to ologen.
3Collagen Matrix and Bandage Lens CE certificates attained.
2Aeon Astron Europe B.V. ISO 13485 certificate was obtained.
1Aeon Astron Europe B.V. was established.
2007
MonthTitle
11Body Organ Biomedical Corporation attained ISO 13485:2003 certificate.
5Body Organ Biomedical Corporation was established.
TOP
Copyright © Body Organ Biomedical Corp. All rights reserved.
Last updated on:2017-04-05